Encompass Health Corp (EHC) Receives $76.38 Consensus PT from Brokerages

Encompass Health Corp (AMEX:EHC) has received a consensus rating of “Buy” from the eleven ratings firms that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have issued a buy rating on the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $76.38.

Separately, Zacks Investment Research cut Encompass Health from a “buy” rating to a “hold” rating in a research note on Wednesday, January 9th.

In other news, Director Leo I. Higdon, Jr. acquired 1,000 shares of the business’s stock in a transaction on Thursday, March 7th. The shares were purchased at an average price of $58.84 per share, for a total transaction of $58,840.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.60% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in EHC. Bank of New York Mellon Corp raised its stake in Encompass Health by 1.5% during the third quarter. Bank of New York Mellon Corp now owns 1,433,372 shares of the company’s stock valued at $111,731,000 after buying an additional 21,766 shares in the last quarter. Franklin Resources Inc. acquired a new stake in Encompass Health during the third quarter valued at approximately $284,000. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Encompass Health during the third quarter valued at approximately $335,000. LPL Financial LLC raised its stake in Encompass Health by 96.3% during the third quarter. LPL Financial LLC now owns 27,848 shares of the company’s stock valued at $2,171,000 after buying an additional 13,661 shares in the last quarter. Finally, BlueMountain Capital Management LLC raised its stake in Encompass Health by 12.7% during the third quarter. BlueMountain Capital Management LLC now owns 22,676 shares of the company’s stock valued at $1,768,000 after buying an additional 2,555 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Encompass Health has a one year low of $40.86 and a one year high of $59.29.

Encompass Health (AMEX:EHC) last released its quarterly earnings results on Thursday, February 7th. The company reported $0.80 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.79 by $0.01. The business had revenue of $1.10 billion during the quarter, compared to analyst estimates of $1.09 billion. During the same quarter last year, the firm posted $0.70 EPS. The company’s revenue was up 8.6% compared to the same quarter last year.

The company also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of ∞. The ex-dividend date of this dividend was Friday, March 29th.

Encompass Health Company Profile

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Read More: Trading Strategy Examples and Plans

Analyst Recommendations for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.